Search bioRxiv⌕ Search

Biology subjects

Prasad, B. V.

Publications and source records attributed to Prasad, B. V..

2 recordsLinked to original sources

Structure of Orthoreovirus RNA Chaperone σNS, a Component of Viral Replication Factories

The reovirus {sigma}NS RNA-binding protein is required for formation of intracellular compartments during viral infection that support viral genome replication and capsid assembly. Despite its functional importance, a mechanistic understanding of {sigma}NS is lacking. We conducted structural and biochemical analyses of an R6A mutant of {sigma}NS that forms dimers instead of the higher-order oligomers formed by wildtype (WT) {sigma}NS. The crystal structure of selenomethionine-substituted {sigma}NS-R6A reveals that the mutant protein forms a stable antiparallel dimer, with each subunit having a well-folded central core and a projecting N-terminal arm. The dimers interact with each other by inserting the N-terminal arms into a hydrophobic pocket of the neighboring dimers on either side to form a helical assembly that resembles filaments of WT {sigma}NS in complex with RNA observed using cryo-EM. The interior of the crystallographic helical assembly is positively charged and of appropriate diameter to bind RNA. The helical assembly is disrupted by bile acids, which bind to the same hydrophobic pocket as the N-terminal arm, as demonstrated in the crystal structure of {sigma}NS-R6A in complex with bile acid. This finding suggests that the N-terminal arm functions in conferring context-dependent oligomeric states of {sigma}NS, which is supported by the structure of {sigma}NS lacking the N-terminal arm. We discovered that {sigma}NS displays RNA helix destabilizing and annealing activities, likely essential for presenting mRNA to the viral RNA-dependent RNA polymerase for genome replication. The RNA chaperone activity is reduced by bile acids and abolished by N-terminal arm deletion, suggesting that the activity requires formation of {sigma}NS oligomers. Our studies provide structural and mechanistic insights into the function of {sigma}NS in reovirus replication.

biochemistry↗

In silico approach for designing of a multi-epitope based vaccine against novel Coronavirus (SARS-COV-2)

A novel Coronavirus (SARS-COV-2) has now become a global pandemic. Considering the severity of infection and the associated mortalities, there is an urgent need to develop an effective preventive measure against this virus. In this study, we have designed a novel vaccine construct using computational strategies. Spike (S) glycoprotein is the major antigenic component that trigger the host immune responses. Detailed investigation of S protein with various immunoinformatics tools enabled us to identify 5 MHC I and 5 MHC II B-cell derived T-cell epitopes with VaxiJen score > 1 and IC50 value < 100nM. These epitopes were joined with a suitable adjuvant and appropriate linkers to form a multi-epitope based vaccine construct. Further, in silico testing of the vaccine construct for its antigenicity, allergenicity, solubility, and other physicochemical properties showed it to be safe and immunogenic. Suitable tertiary structure of the vaccine protein was generated using 3Dpro of SCRATCH suite, refined with GalaxyRefine, and validated with ProSA, PROCHECK, and ERRAT server. Finally, molecular docking studies were performed to ensure a favorable binding affinity between the vaccine construct and TLR3 receptor. The designed multi-epitope vaccine showed potential to elicit specific immune responses against the SARS-COV-2. However, further wet lab validation is necessary to confirm the actual effectiveness, safety and immunogenic potency of the vaccine construct against derived in this study.

bioinformatics↗